mAbs · 2013 · 205 citations · 65 references
PharmacyBiochemistryBiotechnologyAntibody EngineeringMonoclonal AntibodiesStructural BiologyAntibody CharacterizationAntibody DiscoveryAntibody Library ConstructionAntibody StabilityAntibody StructureAntigen DesignAggregation PropensityAntibodiesAntibody Library DesignBiophysical CharacterizationFab DisplayFramework RegionsHuman Antibody LibrariesPost-translational Modification Sites
This report describes the design, generation and testing of Ylanthia, a fully synthetic human Fab antibody library with 1.3E+11 clones. Ylanthia comprises 36 fixed immunoglobulin (Ig) variable heavy (VH)/variable light (VL) chain pairs, which cover a broad range of canonical complementarity-determining region (CDR) structures. The variable Ig heavy and Ig light (VH/VL) chain pairs were selected for biophysical characteristics favorable to manufacturing and development. The selection process included multiple parameters, e.g., assessment of protein expression yield, thermal stability and aggregation propensity in fragment antigen binding (Fab) and IgG1 formats, and relative Fab display rate on phage. The framework regions are fixed and the diversified CDRs were designed based on a systematic analysis of a large set of rearranged human antibody sequences. Care was taken to minimize the occurrence of potential posttranslational modification sites within the CDRs. Phage selection was performed against various antigens and unique antibodies with excellent biophysical properties were isolated. Our results confirm that quality can be built into an antibody library by prudent selection of unmodified, fully human VH/VL pairs as scaffolds.
65
Continuous cultures of fused cells secreting antibody of predefined specificity
Georges Köhler, César Milstein · Nature · 1975 · 17.2K citations
Pharmacy, Cell Biology, Immunology +11
Phage antibodies: filamentous phage displaying antibody variable domains
John McCafferty, Andrew D. Griffiths, Greg Winter et al. · Nature · 1990 · 2.4K citations
Predominant Autoantibody Production by Early Human B Cell Precursors
Hedda Wardemann, Sergey Yurasov, Anne Schaefer et al. · Science · 2003 · 2.1K citations
Humanization of an anti-p185HER2 antibody for human cancer therapy.
Paul Carter, Leonard G. Presta, C Gorman et al. · Proceedings of the National Academy of Sciences · 1992 · 1.9K citations